Diminished expression of ING1 mRNA and the correlation with p53 expressionin breast cancers

Citation
E. Tokunaga et al., Diminished expression of ING1 mRNA and the correlation with p53 expressionin breast cancers, CANCER LETT, 152(1), 2000, pp. 15-22
Citations number
23
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER LETTERS
ISSN journal
03043835 → ACNP
Volume
152
Issue
1
Year of publication
2000
Pages
15 - 22
Database
ISI
SICI code
0304-3835(20000428)152:1<15:DEOIMA>2.0.ZU;2-I
Abstract
p33(ING1) is a novel candidate tumor suppressor and its overexpression indu ces growth arrest or apoptosis in different cell lines. These functions of p33(ING1) depend largely on the activity of p53, and p53-dependent activati on of the transcription from the p21/WAF1 promoter also requires p33(ING1). We examined the expression of ING1 mRNA in breast cancer cell lines and cl inical breast cancer tissues, using quantitative RT-PCR and real time TaqMa n(TM) technology. In breast cancer cell lines, ING1 mRNA was expressed at a lmost the same level. However, in a comparison between the cancer and match ed normal tissues, a significant decrease in ING1 mRNA expression was found in 17 of 24 (70.8%) breast cancer tissues. We also examined the correlatio n between ING1 mRNA expression and p53 expression. There was a significant decrease of ING1 mRNA in nine of 15 tumors negative for p53 immunostaining, most of which were considered to have wild type p53. In these tumors, p53 may not function in case of a decreased expression of p33(ING1), and the la ck of cell cycle regulation may correlate with the carcinogenesis and tumor progression. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.